Analysis finds savings with transradial access

03/31/2013 | CardiovascularBusiness.com

Percutaneous coronary intervention using the transradial approach reduces hospital costs by an average of $553 compared with the transfemoral route, largely due to shorter post-procedure hospital stays, according to an analysis published in the American Heart Journal. Low-, medium- and high-risk patients in the transradial group all experienced a lower rate of in-hospital bleeding complications than those who received transfemoral treatment, according to the study.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT